Evidence map›Paper›PMID 32632206›Full record

ArticleMolecular psychiatry2021

Older molecular brain age in severe mental illness.

Chien-Wei Lin, Lun-Ching Chang, Tianzhou Ma, Hyunjung Oh, Beverly French, Rachel Puralewski, Fasil Mathews, Yusi Fang, David A Lewis, James L Kennedy and 11 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Structural MRI-Based Measures of Accelerated Brain Aging do not Moderate the Acute Antidepressant Response in Late-Life Depression.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2022
    Trial
  3. Article
  4. Article
  5. Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  6. Article
  7. GABADrug design, development and therapy · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 3 countries.

Chien-Wei Lin *Department of Biostatistics, Graduate school of Public Health, University of Pittsburgh, Pittsburgh, PA, 15261, USA.ORCID http://orcid.org/0000-0003-4023-7339
Lun-Ching Chang *Department of Biostatistics, Graduate school of Public Health, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Tianzhou MaDepartment of Biostatistics, Graduate school of Public Health, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Hyunjung OhDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15312, USA.
Beverly FrenchDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15312, USA.ORCID http://orcid.org/0000-0001-8848-0093
Rachel PuralewskiDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15312, USA.
Fasil MathewsDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15312, USA.
Yusi FangDepartment of Biostatistics, Graduate school of Public Health, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
David A LewisDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15312, USA.ORCID http://orcid.org/0000-0002-3225-6778
James L KennedyCampbell Family Mental Health Research Institute of CAMH, Department of Psychiatry, University of Toronto, Toronto, M5T1R8, ON, Canada.ORCID http://orcid.org/0000-0002-8733-3806
Daniel MuellerCampbell Family Mental Health Research Institute of CAMH, Department of Psychiatry, University of Toronto, Toronto, M5T1R8, ON, Canada.
Victoria S MarsheCampbell Family Mental Health Research Institute of CAMH, Department of Psychiatry, University of Toronto, Toronto, M5T1R8, ON, Canada.
Andrew JaffeLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA.ORCID http://orcid.org/0000-0001-6886-1454
Qiang ChenLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA.
Gianluca UrsiniLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA.
Daniel WeinbergerLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA.ORCID http://orcid.org/0000-0003-2409-2969
Anne B NewmanDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Eric J LenzeDepartment of Psychiatry, Washington University, St. Louis, MO, 63130, USA.
Yuliya S NikolovaCampbell Family Mental Health Research Institute of CAMH, Department of Psychiatry, University of Toronto, Toronto, M5T1R8, ON, Canada.
George C TsengDepartment of Biostatistics, Graduate school of Public Health, University of Pittsburgh, Pittsburgh, PA, 15261, USA. ctseng@pitt.edu.
Etienne SibilleDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15312, USA. Etienne.sibille@camh.ca.ORCID http://orcid.org/0000-0001-5832-6570
University of Pittsburgh · USLieber Institute for Brain Development · USUniversity of Toronto · CACentre for Addiction and Mental Health · CAWashington University in St. Louis · US

Funding

Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES IN THE AGING BRAINP01AG002219 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI HAROUTUNIAN, VAHRAM · 1985 to 2009
$19.2M
White Matter Abnormalities in SchizophreniaP50MH066392 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BUXBAUM, JOSEPH D. · 2002 to 2012
$18.6M
Pathway discovery, validation and compound identification for Alzheimer's disease - SupplementU01AG046152 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2013 to 2017
$13.6M
Project 5: In vivo measurement of GABA transmission in healthy controls & subjectP50MH084053 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEWIS, DAVID A · 2008 to 2012
$11.5M
International Cohort Collection for Bipolar DisorderR01MH085542 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SMOLLER, JORDAN W · 2008 to 2012
$10.7M
Cis-Regulatory Epigenome Mappings in SchizophreniaU01MH103392 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AKBARIAN, SCHAHRAM, SKLAR, PAMELA · 2014 to 2017
$7.6M
Molecular Profiling of SchizophreniaR01MH110921 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHESS, ANDREW J, ROUSSOS, PANAGIOTIS · 2016 to 2020
$6.9M
NCI NIH HHS R01 CA190766NIA NIH HHS N01 AG062101NIA NIH HHS N01 AG062103NIA NIH HHS P01 AG002219NIA NIH HHS P30 AG010161NIA NIH HHS P50 AG005138NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG028050NIA NIH HHS R01 AG028288NIA NIH HHS R01 AG030146NIA NIH HHS R01 AG036836NIA NIH HHS U01 AG032984NIA NIH HHS U01 AG046152NIDA NIH HHS HHSN271201300031CNIMH NIH HHS P50 MH066392NIMH NIH HHS P50 MH084053NIMH NIH HHS R01 MH075916NIMH NIH HHS R01 MH080405NIMH NIH HHS R01 MH085542NIMH NIH HHS R01 MH093723NIMH NIH HHS R01 MH093725NIMH NIH HHS R01 MH097276NIMH NIH HHS R01 MH109677NIMH NIH HHS R01 MH109897NIMH NIH HHS R01 MH110921NIMH NIH HHS R37 MH057881NIMH NIH HHS U01 MH103392NINR NIH HHS R01 NR012459
6 · The paper itself

Abstract

Psychiatric disorders are associated with accelerated aging and enhanced risk for neurodegenerative disorders. Brain aging is associated with molecular, cellular, and structural changes that are robust on the group level, yet show substantial inter-individual variability. Here we assessed deviations in gene expression from normal age-dependent trajectories, and tested their validity as predictors of risk for major mental illnesses and neurodegenerative disorders. We performed large-scale gene expression and genotype analyses in postmortem samples of two frontal cortical brain regions from 214 control subjects aged 20-90 years. Individual estimates of "molecular age" were derived from age-dependent genes, identified by robust regression analysis. Deviation from chronological age was defined as "delta age". Genetic variants associated with deviations from normal gene expression patterns were identified by expression quantitative trait loci (cis-eQTL) of age-dependent genes or genome-wide association study (GWAS) on delta age, combined into distinct polygenic risk scores (PRS

Indexed as

Major Depressive DisorderMental DisordersBrainGenetic Predisposition to DiseaseGenome-Wide Association StudyHumans

Identifiers

PMID32632206
PMCPMC7785531
OpenAlexW3040050420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.